These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 19164407

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A novel case of t(X;1)(p11.2;p34) in a renal cell carcinoma with TFE3 rearrangement and favorable outcome in a 57-year-old patient.
    Haudebourg J, Hoch B, Fabas T, Burel-Vandenbos F, Carpentier X, Amiel J, Cardot-Leccia N, Michiels JF, Pedeutour F.
    Cancer Genet Cytogenet; 2010 Jul 15; 200(2):75-8. PubMed ID: 20620589
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum.
    Rao Q, Williamson SR, Zhang S, Eble JN, Grignon DJ, Wang M, Zhou XJ, Huang W, Tan PH, Maclennan GT, Cheng L.
    Am J Surg Pathol; 2013 Jun 15; 37(6):804-15. PubMed ID: 23598965
    [Abstract] [Full Text] [Related]

  • 8. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.
    Altinok G, Kattar MM, Mohamed A, Poulik J, Grignon D, Rabah R.
    Pediatr Dev Pathol; 2005 Jun 15; 8(2):168-80. PubMed ID: 15747097
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
    Mosquera JM, Dal Cin P, Mertz KD, Perner S, Davis IJ, Fisher DE, Rubin MA, Hirsch MS.
    Diagn Mol Pathol; 2011 Sep 15; 20(3):129-37. PubMed ID: 21817901
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Research advances in Xp11.2 translocation renal cell carcinoma].
    Huang JH, Zhou FJ.
    Ai Zheng; 2008 Sep 15; 27(9):1006-8. PubMed ID: 18799045
    [Abstract] [Full Text] [Related]

  • 20. Pediatric renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.
    Winarti NW, Argani P, De Marzo AM, Hicks J, Mulyadi K.
    Int J Surg Pathol; 2008 Jan 15; 16(1):66-72. PubMed ID: 18203790
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.